Source: International Congress 2017 – Novel mechanisms in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Mauri (SEGRATE (MI), Italy). Proteomics analysis of asthma biomarkers: proxima sub-study. 1163

Member's Comments

No comment yet.

Related content which might interest you: Metabolomic analysis of severe COPD. Study of biomarkers in the CHAIN cohort. Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Novel proteomic biomarkers in the evaluation of childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Parametric response mapping of COPD phenotypes: A COPDGene study Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015 Whole transcriptome analysis in peripheral blood from asthmatic and healthy subjects in the U-BIOPRED study Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Cluster analysis on longitudinal data of patients with adult-onset asthma Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 A CADSET WP4 transcriptomic analysis of Asthma and COPD overlap Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Multivariate cluster analysis of immunopathological and clinical data from the U-BIOPRED severe asthma study: Preliminary results Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Unbiased cluster analysis of severe asthma based on metabolomics by the U-BIOPRED electronic nose platform Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Observational study to characterise 24-hour COPD symptoms: Interim analysis of ASSESS Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Transcriptome analysis of controlled and problematic severe childhood asthma Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Environment and lung function in adults with asthma: an exposome approach in the EGEA study Source: International Congress 2019 – Air pollution: from early life, the home environment to going underground Year: 2019